These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 28673572)

  • 21. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.
    Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M
    J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DIABLO/SMAC mimetics selectively kill HIV-1-infected resting memory CD4
    Campbell GR; Spector SA
    Autophagy; 2019 Apr; 15(4):744-746. PubMed ID: 30653393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2 Antagonist Obatoclax Reactivates Latent HIV-1 via the NF-κB Pathway and Induces Latent Reservoir Cell Apoptosis in Latently Infected Cells.
    Zhou C; Li T; Xia M; Wu Z; Zhong X; Li A; Rashid HK; Ma C; Zhou R; Duan H; Zhang X; Peng J; Li L
    ACS Infect Dis; 2023 Nov; 9(11):2105-2118. PubMed ID: 37796279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4⁺ memory T Cells.
    Jaafoura S; de Goër de Herve MG; Hernandez-Vargas EA; Hendel-Chavez H; Abdoh M; Mateo MC; Krzysiek R; Merad M; Seng R; Tardieu M; Delfraissy JF; Goujard C; Taoufik Y
    Nat Commun; 2014 Nov; 5():5407. PubMed ID: 25382623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4
    Lu X; Song B; Weng W; Xia H; Su B; Wu H; Zhang T; Li W; Gao Y
    Viral Immunol; 2017 Nov; 30(9):642-648. PubMed ID: 29035156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2.
    French AJ; Natesampillai S; Krogman A; Correia C; Peterson KL; Alto A; Chandrasekar AP; Misra A; Li Y; Kaufmann SH; Badley AD; Cummins NW
    PLoS Pathog; 2020 Oct; 16(10):e1008906. PubMed ID: 33075109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic Profiling of a Primary CD4
    Saha JM; Liu H; Hu PW; Nikolai BC; Wu H; Miao H; Rice AP
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):103-110. PubMed ID: 29084447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
    Siliciano JD; Siliciano RF
    J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and strategies for the eradication of the HIV reservoir.
    Kimata JT; Rice AP; Wang J
    Curr Opin Immunol; 2016 Oct; 42():65-70. PubMed ID: 27288651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of HIV-1 latency by T-cell activation.
    Williams SA; Greene WC
    Cytokine; 2007 Jul; 39(1):63-74. PubMed ID: 17643313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell type-specific HIV-1 activation in effector T cells: implications for latent HIV-1 reservoir establishment.
    van der Sluis RM; van Capel TM; Speijer D; Sanders RW; Berkhout B; de Jong EC; Jeeninga RE; van Montfort T
    AIDS; 2015 Jun; 29(9):1003-14. PubMed ID: 25768834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T memory stem cells and HIV: a long-term relationship.
    Chahroudi A; Silvestri G; Lichterfeld M
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):33-40. PubMed ID: 25578055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell-like memory T cells: A perspective from the dark side.
    Gao S; Liang X; Wang H; Bao B; Zhang K; Zhu Y; Shao Q
    Cell Immunol; 2021 Mar; 361():104273. PubMed ID: 33422699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of immune-modulating compounds to disrupt HIV latency.
    Remoli AL; Marsili G; Battistini A; Sgarbanti M
    Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of HIV latency during thymopoiesis.
    Brooks DG; Kitchen SG; Kitchen CM; Scripture-Adams DD; Zack JA
    Nat Med; 2001 Apr; 7(4):459-64. PubMed ID: 11283673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in the Role of Stem Memory T Cells in HIV-1 Infection].
    Lu X; Li L; Xia H; Wu H; Su B; Zhang T
    Bing Du Xue Bao; 2016 Nov; 32(6):796-9. PubMed ID: 30004654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reservoir for HIV in patients on combination antiretroviral therapy.
    Siliciano RF
    Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.
    Cummins NW; Sainski AM; Dai H; Natesampillai S; Pang YP; Bren GD; de Araujo Correia MCM; Sampath R; Rizza SA; O'Brien D; Yao JD; Kaufmann SH; Badley AD
    J Virol; 2016 Apr; 90(8):4032-4048. PubMed ID: 26842479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.